Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EGFR | P00533 | 17/20 | 0.48 |
| ▸ | KDR | P35968 | 7/20 | 0.44 |
| ▸ | HDAC3 | O15379 | 6/20 | 0.41 |
| ▸ | HDAC4 | P56524 | 6/20 | 0.41 |
| ▸ | HDAC1 | Q13547 | 6/20 | 0.41 |
| ▸ | HDAC7 | Q8WUI4 | 6/20 | 0.41 |
| ▸ | HDAC2 | Q92769 | 6/20 | 0.41 |
| ▸ | HDAC10 | Q969S8 | 6/20 | 0.41 |
| ▸ | HDAC11 | Q96DB2 | 6/20 | 0.41 |
| ▸ | HDAC8 | Q9BY41 | 6/20 | 0.41 |
| ▸ | HDAC6 | Q9UBN7 | 6/20 | 0.41 |
| ▸ | HDAC9 | Q9UKV0 | 6/20 | 0.41 |
| ▸ | HDAC5 | Q9UQL6 | 6/20 | 0.41 |
| ▸ | ERBB2 | P04626 | 5/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7244436 | 0.86 | EGFR (0.47) | EGFRKDRHDAC3HDAC4HDAC1 | |
| SCHEMBL8151436 | 0.86 | EGFR (0.55) | EGFRKDRHDAC3HDAC4HDAC1 | |
| SCHEMBL7238302 | 0.80 | EGFR (0.47) | EGFRKDRHDAC3HDAC4HDAC1 | |
| Hydrochloric Acid SCHEMBL8310513 | 0.79 | KDR (0.61) | EGFRKDRERBB2 | |
| SCHEMBL8155324 | 0.78 | EGFR (0.55) | EGFRKDRHDAC3HDAC4HDAC1 | |
| SCHEMBL7121754 | 0.77 | EGFR (0.54) | EGFRKDRERBB2 | |
| SCHEMBL7235690 | 0.76 | EGFR (0.55) | EGFRERBB2 | |
| SCHEMBL7238978 | 0.70 | EGFR (0.67) | EGFRKDRERBB2 | |
| SCHEMBL7124614 | 0.69 | EGFR (0.44) | EGFRKDRHDAC3HDAC4HDAC1 | |
| SCHEMBL17520361 | 0.67 | EGFR (0.94) | EGFRKDRERBB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6562818-B1 | For treating cancer, atherosclerosis, restenosis, endometriosis, and psoriasis | WARNER-LAMBERT COMPANY | 2003-05-13 | — | — | US | disclosed |
| US-6127374-A | AN ENZYME INHIBITOR FOR TREATING CANCER, RESTENOSIS, ATHEROSCLEROSIS, ENDOMETRIOSIS AND PSORIASIS | WARNER-LAMBERT COMPANY (US) | 2000-10-03 | — | — | US | disclosed |